Hedera Dx News

Filter
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Announcement

October 17, 2023

Hedera Dx Launches Blood Based Cancer Testing That Allows Larger Patient Populations to Access Cancer Therapies

Learn More
Announcement

October 17, 2023

Hedera Dx Launches Blood Based Cancer Testing That Allows Larger Patient Populations to Access Cancer Therapies

Learn More
Webcast

December 14, 2022

Utilité clinique des biopsies liquides en France en 2023

Learn More
Webcast

December 14, 2022

Utilité clinique des biopsies liquides en France en 2023

Learn More
Press

October 26, 2022

Hedera Dx Hopes to Hasten Liquid Biopsy Adoption in Europe with Streamlined Platform

Learn More
Press

October 26, 2022

Hedera Dx Hopes to Hasten Liquid Biopsy Adoption in Europe with Streamlined Platform

Learn More
Press

October 21, 2022

VCs move on from Theranos “bad blood” as liquid biopsy startups flourish

Learn More
Press

October 21, 2022

VCs move on from Theranos “bad blood” as liquid biopsy startups flourish

Learn More
Press

September 21, 2022

Minute Insight: Hedera DX Completes €14m Raise To Fund ML-Backed Liquid Biopsy Tech

Learn More
Press

September 21, 2022

Minute Insight: Hedera DX Completes €14m Raise To Fund ML-Backed Liquid Biopsy Tech

Learn More
Announcement

September 21, 2022

Hedera Dx raises €14 million in seed funding to accelerate global adoption of liquid biopsies

Learn More
Announcement

September 21, 2022

Hedera Dx raises €14 million in seed funding to accelerate global adoption of liquid biopsies

Learn More

Media Kit

To feature Hedera Dx please use our official logos and imagery.

Download our media kit